首页> 外文期刊>亚太热带医药杂志(英文版) >In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses
【24h】

In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses

机译:Nipah和Hendra病毒的常见基于表位的肽疫苗的计算机鉴定和表征

获取原文
获取原文并翻译 | 示例
           

摘要

Objective:To explore a common B- and T- cell epitope-based vaccine that can elicit an immune response against encephalitis causing genus Henipaviruses, Hendra virus (HeV) and Nipah virus (NiV).Methods: Membrane proteins F, G and M of HeV and NiV were retrieved from the protein database and subjected to different bioinformatics tools to predict antigenic B- cell epitopes. Best B- cell epitopes were then analyzed to predict their T- cell antigenic potentiality. Antigenic B- and T- cell epitopes that shared maximum identity with HeV and NiV were selected. Stability of the selected epitopes was predicted. Finally, the selected epitopes were subjected to molecular docking simulation with HLA-DR to confirm their antigenic potentiality in silico.Results:One epitope from G proteins, one from M proteins and none from F proteins were selected based on their antigenic potentiality. The epitope from the G proteins was stable whereas that from M was unstable. The M-epitope was made stable by adding flanking dipeptides. The 15-mer G-epitope (VDPLRVQWRNNSVIS) showed at least 66% identity with all NiV and HeV G protein sequences, while the 15-mer M-epitope (GKLEFRRNNAIAFKG) with the dipeptide flanking residues showed 73% identity with all NiV and HeV M protein sequences available in the database. Molecular docking simulation with most frequent MHC class-II (MHC II) and class-I (MHC I) molecules showed that these epitopes could bind within HLA binding grooves to elicit an immune response.Conclusions:Data in our present study revealed the notion that the epitopes from G and M proteins might be the target for peptide-based subunit vaccine design against HeV and NiV. However, the biochemical analysis is necessary to experimentally validate the interaction of epitopes individually with the MHC molecules through elucidation of immunity induction.
机译:目的:探讨一种常见的基于B细胞和T细胞抗原决定簇的疫苗,该疫苗可引起针对引起脑炎的肝炎病毒,亨德拉病毒(HeV)和尼帕病毒(NiV)的免疫反应。方法:膜蛋白F,G和M从蛋白质数据库中检索到HeV和NiV,并对其进行了不同的生物信息学分析,以预测抗原性B细胞表位。然后分析最佳的B细胞表位,以预测其T细胞抗原性。选择了与HeV和NiV具有最大同一性的抗原性B细胞和T细胞表位。预测所选表位的稳定性。最后,对选定的抗原决定簇进行HLA-DR分子对接模拟,以验证其抗原性。结果:根据抗原性,从G蛋白中选择一个抗原表位,从M蛋白中选择一个抗原表位,从F蛋白中选择一个抗原表位。来自G蛋白的表位是稳定的,而来自M蛋白的表位是不稳定的。通过添加侧翼二肽使M-表位稳定。 15-mer G表位(VDPLRVQWRNNSVIS)与所有NiV和HeV G蛋白序列具有至少66%的同一性,而15-mer M表位(GKLEFRRNNAIAFKG)具有二肽侧翼残基与所有NiV和HeV具有73%的同一性数据库中有M个蛋白质序列。分子对接模拟最常见的MHC II类(MHC II)和I类(MHC I)分子表明,这些表位可以在HLA结合槽内结合以引发免疫反应。结论:本研究的数据揭示了这样一个概念: G和M蛋白的表位可能是针对HeV和NiV的基于肽的亚基疫苗设计的目标。但是,通过阐明免疫诱导,通过实验验证表位与MHC分子的相互作用,生化分析是必要的。

著录项

  • 来源
    《亚太热带医药杂志(英文版)》 |2017年第6期|601-608|共8页
  • 作者单位

    Department of Genetic Engineering & Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh;

    Department of Genetic Engineering & Biotechnology, University of Chittagong, Chittagong-4331, Bangladesh;

    Department of Genetic Engineering & Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh;

    Department of Genetic Engineering & Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh;

    Department of Genetic Engineering & Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号